These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 36519135)

  • 41. Oligoribonuclease is required for the type III secretion system and pathogenesis of Pseudomonas aeruginosa.
    Chen G; Zhao Q; Zhu F; Chen R; Jin Y; Liu C; Pan X; Jin S; Wu W; Cheng Z
    Microbiol Res; 2016; 188-189():90-96. PubMed ID: 27296966
    [TBL] [Abstract][Full Text] [Related]  

  • 42. DNA alternate polymerase PolB mediates inhibition of type III secretion in Pseudomonas aeruginosa.
    Chakravarty S; Ramos-Hegazy L; Gasparovic A; Anderson GG
    Microbes Infect; 2021; 23(2-3):104777. PubMed ID: 33276123
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Discovery and characterization of inhibitors of Pseudomonas aeruginosa type III secretion.
    Aiello D; Williams JD; Majgier-Baranowska H; Patel I; Peet NP; Huang J; Lory S; Bowlin TL; Moir DT
    Antimicrob Agents Chemother; 2010 May; 54(5):1988-99. PubMed ID: 20176902
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A new regulator of pathogenicity (bvlR) is required for full virulence and tight microcolony formation in Pseudomonas aeruginosa.
    McCarthy RR; Mooij MJ; Reen FJ; Lesouhaitier O; O'Gara F
    Microbiology (Reading); 2014 Jul; 160(Pt 7):1488-1500. PubMed ID: 24829363
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular insights into the master regulator CysB-mediated bacterial virulence in Pseudomonas aeruginosa.
    Song Y; Yang C; Chen G; Zhang Y; Seng Z; Cai Z; Zhang C; Yang L; Gan J; Liang H
    Mol Microbiol; 2019 May; 111(5):1195-1210. PubMed ID: 30618115
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pore-forming activity of the Pseudomonas aeruginosa type III secretion system translocon alters the host epigenome.
    Dortet L; Lombardi C; Cretin F; Dessen A; Filloux A
    Nat Microbiol; 2018 Mar; 3(3):378-386. PubMed ID: 29403015
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The type III secretion system of Pseudomonas aeruginosa: infection by injection.
    Hauser AR
    Nat Rev Microbiol; 2009 Sep; 7(9):654-65. PubMed ID: 19680249
    [TBL] [Abstract][Full Text] [Related]  

  • 48. H-NS Family Members MvaT and MvaU Regulate the Pseudomonas aeruginosa Type III Secretion System.
    Williams McMackin EA; Marsden AE; Yahr TL
    J Bacteriol; 2019 Jul; 201(14):. PubMed ID: 30782629
    [No Abstract]   [Full Text] [Related]  

  • 49. Novel humanized anti-PcrV monoclonal antibody COT-143 protects mice from lethal
    Numata S; Hara T; Izawa M; Okuno Y; Sato Y; Yamane S; Maki H; Sato T; Yamano Y
    Antimicrob Agents Chemother; 2024 Oct; 68(10):e0069424. PubMed ID: 39269189
    [TBL] [Abstract][Full Text] [Related]  

  • 50. tRNA modification enzyme MiaB connects environmental cues to activation of Pseudomonas aeruginosa type III secretion system.
    Lin Q; Huang J; Liu Z; Chen Q; Wang X; Yu G; Cheng P; Zhang LH; Xu Z
    PLoS Pathog; 2022 Dec; 18(12):e1011027. PubMed ID: 36469533
    [TBL] [Abstract][Full Text] [Related]  

  • 51. TpiA is a Key Metabolic Enzyme That Affects Virulence and Resistance to Aminoglycoside Antibiotics through CrcZ in Pseudomonas aeruginosa.
    Xia Y; Wang D; Pan X; Xia B; Weng Y; Long Y; Ren H; Zhou J; Jin Y; Bai F; Cheng Z; Jin S; Wu W
    mBio; 2020 Jan; 11(1):. PubMed ID: 31911486
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The type III secretion system facilitates systemic infections of
    Wu T; Zhang Z; Li T; Dong X; Wu D; Zhu L; Xu K; Zhang Y
    Microbiol Spectr; 2024 Jan; 12(1):e0222423. PubMed ID: 38088541
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Derivatives of plant phenolic compound affect the type III secretion system of Pseudomonas aeruginosa via a GacS-GacA two-component signal transduction system.
    Yamazaki A; Li J; Zeng Q; Khokhani D; Hutchins WC; Yost AC; Biddle E; Toone EJ; Chen X; Yang CH
    Antimicrob Agents Chemother; 2012 Jan; 56(1):36-43. PubMed ID: 21968370
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Backbone Interactions Between Transcriptional Activator ExsA and Anti-Activator ExsD Facilitate Regulation of the Type III Secretion System in Pseudomonas aeruginosa.
    Shrestha M; Bernhards RC; Fu Y; Ryan K; Schubot FD
    Sci Rep; 2020 Jun; 10(1):9881. PubMed ID: 32555263
    [TBL] [Abstract][Full Text] [Related]  

  • 55. PscI is a type III secretion needle anchoring protein with in vitro polymerization capacities.
    Monlezun L; Liebl D; Fenel D; Grandjean T; Berry A; Schoehn G; Dessein R; Faudry E; Attree I
    Mol Microbiol; 2015 Apr; 96(2):419-36. PubMed ID: 25614137
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pseudomonas aeruginosa injects NDK into host cells through a type III secretion system.
    Neeld D; Jin Y; Bichsel C; Jia J; Guo J; Bai F; Wu W; Ha UH; Terada N; Jin S
    Microbiology (Reading); 2014 Jul; 160(Pt 7):1417-1426. PubMed ID: 24699069
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Exoenzyme Y Contributes to End-Organ Dysfunction Caused by
    Wagener BM; Anjum N; Christiaans SC; Banks ME; Parker JC; Threet AT; Walker RR; Isbell KD; Moser SA; Stevens T; Alexeyev MF; Audia JP; Richter W; Hardy KS; Saleh LA; Morgan C; Pittet JF
    Toxins (Basel); 2020 Jun; 12(6):. PubMed ID: 32512716
    [No Abstract]   [Full Text] [Related]  

  • 58. Regulation of T3SS synthesis, assembly and secretion in Pseudomonas aeruginosa.
    Selim H; Radwan TEE; Reyad AM
    Arch Microbiol; 2022 Jul; 204(8):468. PubMed ID: 35810403
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structure and function of the Type III secretion system of Pseudomonas aeruginosa.
    Galle M; Carpentier I; Beyaert R
    Curr Protein Pept Sci; 2012 Dec; 13(8):831-42. PubMed ID: 23305368
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development of loop-mediated isothermal amplification assays for genotyping of Type III Secretion System in Pseudomonas aeruginosa.
    Shi H; Chen Z; Kan J
    Lett Appl Microbiol; 2015 Oct; 61(4):361-6. PubMed ID: 26219625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.